|
注册号: Registration number: |
ChiCTR2500106721 |
|
最近更新日期: Date of Last Refreshed on: |
2025-07-29 10:16:35 |
|
注册时间: Date of Registration: |
2025-07-29 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
学龄期注意缺陷多动障碍患者父母训练的有效性及影响因素研究 |
|
Public title: |
To study the effectiveness and influencing factors of parental training for school-age patients with attention deficit hyperactivity disorder |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
学龄期注意缺陷多动障碍患者父母训练的有效性及影响因素研究 |
|
Scientific title: |
To study the effectiveness and influencing factors of parental training for school-age patients with attention deficit hyperactivity disorder |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王美雯 |
研究负责人: |
黄颐 |
|
Applicant: |
Meiwen Wang |
Study leader: |
Yi Huang |
|
申请注册联系人电话: Applicant telephone: |
+86 152 8412 4610 |
研究负责人电话:
Study leader's |
+86 189 8060 1705 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
804232877@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
Huangyu@scu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国四川省成都市武侯区电信南街28号 |
研究负责人通讯地址: |
中国四川省成都市武侯区电信南街28号 |
|
Applicant address: |
No. 28, South Telecom Street, Wuhou District, Chengdu, Sichuan, China |
Study leader's address: |
No. 28, South Telecom Street, Wuhou District, Chengdu, Sichuan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
610000 |
研究负责人邮政编码: Study leader's postcode: |
610000 |
|
申请人所在单位: |
四川大学华西医院 |
||
|
Applicant's institution: |
West China Hospital, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西医院 |
||
|
Affiliation of the Leader: |
West China Hospital, Sichuan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023年审(953)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西医院生物医学伦理审查委员会 |
||
|
Name of the ethic committee: |
Biomedical Research Ethics Committee of West China Hospital of Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-19 00:00:00 | ||
|
伦理委员会联系人: |
李娜 |
||
|
Contact Name of the ethic committee: |
Na Li |
||
|
伦理委员会联系地址: |
中国四川省成都市武侯区国学巷37号 |
||
|
Contact Address of the ethic committee: |
No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8542 2654 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川大学华西医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国四川省成都市武侯区国学巷37号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
四川省国际科技创新合作项目(2020YFH0049) |
||||||||||||||||||||||
|
Source(s) of funding: |
Sichuan Provincial International Science and Technology Innovation Cooperation Project(2020YFH0049) |
||||||||||||||||||||||
|
研究疾病: |
注意缺陷多动障碍 |
||||||||||||||||||||||
|
Target disease: |
Attention Deficit Hyperactivity Disorder |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探索父母训练能否短期及长期改善学龄期(6-12岁)ADHD患者的核心症状、行为及情绪问题、家庭功能及社会功能 |
||||||||||||||||||||||
|
Objectives of Study: |
Determine the efficacy of parent training (PT) for children with ADHD,confirming whether it is effective in ADHD symptoms, conduct problem and parenting stress. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)患其他神经发育障碍疾病(不需药物干预的抽动障碍除外); 2)患重大躯体疾病和神经系统疾病,如先天性心脏病,癫痫; 3)曾经或者目前接受其他ADHD父母训练患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Diagnosed with other neurological disorders (except for the tic disorders without medication intervention); 2) Diagnosed with severe physical diseases and nervous system diseases, such as congenital heart disease, epilepsy; 3) Once or currently undergoing other parent training of adhd patients. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-07-01 00:00:00至 To 2024-07-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-02 00:00:00 至 To 2024-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究将进行随机化分组,首先将患者按照年龄、性别进行分层,分层后在组内进行随机分组,不参与研究测查的统计人员使用随机数字生成器排序后以1:1的比例分配至干预组及对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study will be randomized. First of all, the patients were layered according to their age and gender. After layering, the group was randomly packed in the group, statators who do not participate in the research and investigations used random digital generators to sort at a ratio of 1: 1 allocated to the interventiongroup and control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
None |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
https://www.jianguoyun.com(2025年6月27日上传) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
https://www.jianguoyun.com (Uploaded on June 27, 2025) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
1)数据采集方式 纳入儿童的诊断信息、共患病信息、智力的采集方式为面对面评估后使用病例记录表记录,量表测评数据使用问卷星的形式采集,家长扫描相应量表的二维码即可进行填写,采集过程由受过专业培训的研究员完成。 2)数据管理系统 对已经收集的数据使用EXCEL以及SPSS软件进行整理和分析。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
(1) Data collection method Diagnostic information, co-morbidities, and intelligence of the included children were collected in the form of a case record sheet after face-to-face assessment, and the scale assessment data were collected in the form of a questionnaire star, which could be filled in by parents scanning the QR code of the corresponding scale, and the collection process was completed by professionally trained researchers. 2) Data management system The collected data were collated and analysed using EXCEL and SPSS software. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |